Healthcare >> Analyst Interviews >> September 14, 2009
Zarak Khurshid is a Vice President with Caris & Company, covering the medical
diagnostics and life sciences sectors. Prior to joining Caris & Company in 2006,
Mr. Khurshid was a Research Analyst with Pacific Growth Equities, where he
covered the diagnostics and life science tools sectors. Prior to his tenure at
Pacific Growth Equities, Mr. Khurshid spent more than two years with
Cytokinetics, Inc., in the Assay Development group. Previously, Mr. Khurshid
worked at Aurora Biosciences (acquired by Vertex) as an Associate Bioengineer
who developed software and hardware for the company's high throughput screening
system. Mr. Khurshid holds a B.S. in bioengineering and B.A. in economics from
the University of California, San Diego, and he holds Series 7, 63, 86 and 87
securities registrations. Profile
TWST: What segment of the health care industry do you cover and which companies, specifically?
Mr. Khurshid: I cover the diagnostics or medical diagnostics and life sciences
sectors. And in